High NOTCH1-receptor levels have been linked with basal-like, triple-negative (estrogen receptor-, progesterone receptor-, and HER2-negative) breast cancer, and NOTCH1 levels correlate with abbreviated survival [15]. Here, ERBB2 is linked to breast cancer.